Finance
Results: 26893-26904 of 35676

Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completed

VAPORESSO Announces Strategy Upgrade, Building A Comprehensive Service Ecosystem for Varied Premium Vaping Experiences





